These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15946312)
1. Efficacy of mycophenolate mofetil in adult refractory auto-immune cytopenias: a single center preliminary study. Kotb R; Pinganaud C; Trichet C; Lambotte O; Dreyfus M; Delfraissy JF; Tchernia G; Goujard C Eur J Haematol; 2005 Jul; 75(1):60-4. PubMed ID: 15946312 [TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. Howard J; Hoffbrand AV; Prentice HG; Mehta A Br J Haematol; 2002 Jun; 117(3):712-5. PubMed ID: 12028047 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of mycophenolate mofetil as single-agent therapy for refractory immune thrombocytopenic purpura. Provan D; Moss AJ; Newland AC; Bussel JB Am J Hematol; 2006 Jan; 81(1):19-25. PubMed ID: 16369979 [TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil (MMF) for the treatment of steroid-resistant idiopathic thrombocytopenic purpura. Hou M; Peng J; Shi Y; Zhang C; Qin P; Zhao C; Ji X; Wang X; Zhang M Eur J Haematol; 2003 Jun; 70(6):353-7. PubMed ID: 12756016 [TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mophetil therapy for chronic immune thrombocytopenic purpura resistant to steroids, immunosuppressants, and/or splenectomy in adults. Colović M; Suvajdzic N; Colović N; Tomin D; Vidović A; Palibrk V Platelets; 2011; 22(2):153-6. PubMed ID: 21142405 [TBL] [Abstract][Full Text] [Related]
6. A novel immunomodulatory treatment involving mycophenolate mofetil and corticosteroids for pediatric autoimmune cytopenias. Panigrahi A; Clark A; Myers J; Raj A Pediatr Blood Cancer; 2017 Feb; 64(2):287-293. PubMed ID: 27615037 [TBL] [Abstract][Full Text] [Related]
7. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 16 cases. Dufour JF; Pradat P; Ruivard M; Hot A; Dumontet C; Broussolle C; Trepo C; Sève P Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):245-53. PubMed ID: 19279468 [TBL] [Abstract][Full Text] [Related]
8. Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil. Vasoo S; Thumboo J; Fong KY Lupus; 2003; 12(8):630-2. PubMed ID: 12945723 [TBL] [Abstract][Full Text] [Related]
9. Should low-dose mycophenolate mofetil be used to prolong the response after rituximab therapy in patients with immune thrombocytopenic purpura? A case report. Bruserud Ø; Håvardstein K Hematology; 2009 Aug; 14(4):224-6. PubMed ID: 19635186 [TBL] [Abstract][Full Text] [Related]
10. Rituximab therapy has a rapid and durable response for refractory cytopenia in childhood-onset systemic lupus erythematosus. Olfat M; Silverman ED; Levy DM Lupus; 2015 Aug; 24(9):966-72. PubMed ID: 25804672 [TBL] [Abstract][Full Text] [Related]
11. Mycophenolate mofetil therapy for severe immune thrombocytopenia. Taylor A; Neave L; Solanki S; Westwood JP; Terrinonive I; McGuckin S; Kothari J; Cooper N; Stasi R; Scully M Br J Haematol; 2015 Nov; 171(4):625-30. PubMed ID: 26250874 [TBL] [Abstract][Full Text] [Related]
12. Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura. Zhang WG; Ji L; Cao XM; Chen YX; He AL; Liu J; Zhao WH; Zou SP Acta Pharmacol Sin; 2005 May; 26(5):598-602. PubMed ID: 15842780 [TBL] [Abstract][Full Text] [Related]
13. Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study. Dierickx D; Verhoef G; Van Hoof A; Mineur P; Roest A; Triffet A; Kentos A; Pierre P; Boulet D; Bries G; Lê PQ; Janssens A; Delannoy A J Intern Med; 2009 Nov; 266(5):484-91. PubMed ID: 19549092 [TBL] [Abstract][Full Text] [Related]
14. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Shanafelt TD; Madueme HL; Wolf RC; Tefferi A Mayo Clin Proc; 2003 Nov; 78(11):1340-6. PubMed ID: 14601692 [TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group. Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174 [TBL] [Abstract][Full Text] [Related]
16. Different efficacy of mycophenolate mofetil as salvage treatment for acute and chronic GVHD after allogeneic stem cell transplant. Kim JG; Sohn SK; Kim DH; Lee NY; Suh JS; Lee KS; Lee KB Eur J Haematol; 2004 Jul; 73(1):56-61. PubMed ID: 15182339 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mycophenolate mofetil in patients with immune thrombocytopenic purpura: a systematic review and meta-analysis. Abdelwahab OA; Mechi A; Gahlan S; Hamadein FE; Kadhim H; Ismail D; Soliman Y; El-Samahy M Clin Rheumatol; 2024 Feb; 43(2):621-632. PubMed ID: 37981614 [TBL] [Abstract][Full Text] [Related]
18. [Efficiency of mycophenolate mofetil in the treatment of intermediate and posterior uveitis]. Greiner K; Varikkara M; Santiago C; Forrester JV Ophthalmologe; 2002 Sep; 99(9):691-4. PubMed ID: 12219257 [TBL] [Abstract][Full Text] [Related]